PNS240 POTENTIAL INFLUENCE OF HTA ON PRICE OUTCOMES OF NON-ORPHAN PHARMACEUTICALS IN THE GERMAN AMNOG PROCESS

Abstract

Authors

J. Pointner M. Tremmel B. Antoni A.S. Kuschel D. Bonduelle

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×